1259312-25-8

Basic information

• Product Name: 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1-(hydroxymethyl)-3,4-dihydroquinolin-2-(1H )-one
• Synonyms: 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1-(hydroxymethyl)-3,4-dihydroquinolin-2-(1H )-one
• CAS NO: 1259312-25-8
• Molecular Weight: 478.419
• Mol File: 1259312-25-8.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1-(hydroxymethyl)-3,4-dihydroquinolin-2-(1H )-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1-(hydroxymethyl)-3,4-dihydroquinolin-2-(1H )-one(1259312-25-8)
• EPA Substance Registry System: 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1-(hydroxymethyl)-3,4-dihydroquinolin-2-(1H )-one(1259312-25-8)

Safety Data

• Hazardous Substances Data: 1259312-25-8(Hazardous Substances Data)

Upstream product

• 129722-12-9 aripiprazole 
• 50-00-0 formaldehyd 

Downstream Products

• 1259305-29-7 dodecanoic acid [7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2-oxo-1(2H)-quinolinyl]methyl ester 
• 1259305-26-4 (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl) butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl hexanoate 
• 1259305-24-2 (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl butyrate 
• 1259306-40-5 (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxoquinolin-1(2H)-yl)methyl butyrate 
• 628-50-2 carbonochloridic acid 3-methyl-butyl ester 
• 1259305-50-4 (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl) butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl benzylcarbamate 
• 1259305-23-1 (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1 (2H)-yl)methyl acetate 

Relevant articles and documents

PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE LAUROXIL

It is provided a process for the preparation of aripiprazole lauroxil that comprises reacting l-(hydroxymethyl) aripiprazole with lauric anhydride in the presence of DMAP and a solvent.

PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE LAUROXIL

It is provided a process for the preparation of aripiprazole lauroxil that comprises reacting 1-(hydroxymethyl) aripiprazole with lauric acid in the presence of a suitable solvent and a carboxyl activating agent in the presence of a suitable solventand, o

IMPROVED PROCESS FOR THE PREPARATION OF 7-{4-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]BUTOXY}-2OXO-3,4-DIHYDRO-2H-QUINOLIN-1-YL)METHYL DODECANOATE

The present invention relates to improved process for the preparation of 7-{4-[4- (2,3-dichlorophenyl)-piperazin-1-yl]butoxy }-2 oxo-3,4-dihydro-2H-quinolin-1-yl)methyl dodecanoate compound of formula-1, which is represented by the following structural fo